Richard J Rodgers
CIK 1313397 · Interim CEO and President · last filed 2026-04-22
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Loading insider history…
Disclosed Exposure
$2.37M
Companies
7
Total Filings
54
Lifetime Open-Market Net
$0
Holdings By Company
Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| Opus Genetics, Inc. (OCUP) Delisted | Director | 343,022 | $1.17 | $401.3K | $0 | 19 | 2026-04-22 |
| NVAX | Director | 28,490 | $8.88 | $253.0K | $0 | 8 | 2025-10-30 |
| ARDX | Director | 371,992 | $5.69 | $2.12M | $0 | 12 | 2025-06-23 |
| SGMT | Director | — | $6.48 | — | $0 | 1 | 2023-07-20 |
| Opus Genetics, Inc. (RNN) Delisted | Director | — | — | — | $0 | 6 | 2019-06-07 |
| TESARO, Inc. (TSRO) Delisted | Executive VP & CFO | 257,141 | — | — | $0 | 2 | 2013-03-08 |
| MGI PHARMA INC (MOGN) Delisted | Sr. VP & Controller | 4,474 | — | — | $0 | 4 | 2008-01-24 |
Recent Filings · Page 2 of 6
54 filingsForm 4 transactions across all companies, newest first.
| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2024-06-13 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +41,143 | $0 | EDGAR |
| 2024-01-03 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +24,762 | $0 | EDGAR |
| 2023-11-13 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +35,000 | $0 | EDGAR |
| 2023-10-31 | NVAX | Exer (M) | +3,800 | $0 | EDGAR |
| 2023-07-20 | SGMT | Mixed | — | $0 | EDGAR |
| 2023-06-16 | ARDX | Grant (A) | +18,494 | $0 | EDGAR |
| 2023-06-13 | NVAX | Grant (A) | — | $0 | EDGAR |
| 2023-04-21 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +50,000 | $0 | EDGAR |
| 2023-01-12 | Opus Genetics, Inc. (OCUP) Delisted | Grant (A) | +20,822 | $0 | EDGAR |
| 2022-11-01 | NVAX | Grant (A) | — | $0 | EDGAR |
Codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.